- KR₩110bn
- KR₩166bn
- KR₩456bn
- 56
- 89
- 43
- 73
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.98 | ||
| Price to Tang. Book | 1.08 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.24 | ||
| EV to EBITDA | 5.37 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.05% | ||
| Return on Equity | 17.18% | ||
| Operating Margin | 4.92% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 158,967.52 | 166,428.78 | 189,183.03 | 391,821.77 | 456,164.44 | n/a | n/a | 31.11% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +71.57 | n/a | n/a | -69.01 | +878.16 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BioSmart Co., Ltd. is a Korea-based company mainly engaged in credit card business. The Company produces and issues domestic credit cards and electronic money systems under the brand name BS, and provides credit card issuing services, mailing systems, issuing equipment such as embossers and transcribers, and sending machines such as card sending machines and mail sending machines. Its card category includes magnetic stripe cards, integrated circuit (IC) cards, smart cards, combination cards, radio frequency (RF) cards, global systems for mobile communications (GSM) cards and others. The Company also involves in the manufacture of biological chips, cosmetics and health food through its affiliates.
Directors
- Hye Rin Park CHM (49)
- Ho Gwon Yoon CPR (54)
- Gyeong Taek Han CPR (48)
- Jong Yil Yim MDR (53)
- Bong Tae Jang OTH (51)
- Seong Wuk Jang OTH (49)
- Tae Gi Yoon OTH (53)
- Jin Hun Jung DRC (51)
- Yin Geun Hwang NID (44)
- Chang Hwan Lee NID (43)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 30th, 1985
- Public Since
- June 22nd, 2000
- No. of Shareholders
- 14,775
- No. of Employees
- 139
- Sector
- Electronic Equipments & Parts
- Industry
- Technology
- Exchange
Korea Exchange - KOSDAQ- Shares in Issue
- 20,547,227
- Address
- Lyn House, SEOUL, 04791
- Web
- http://www.bio-smart.com/
- Phone
- +82 232189000
- Auditors
- Yeil Accounting
Upcoming Events for 038460
Similar to 038460
ABCO Electronics Co
Korea Exchange - KOSDAQ
Actro Co
Korea Exchange - KOSDAQ
Ajinextek Co
Korea Exchange - KOSDAQ
Amogreentech Co
Korea Exchange - KOSDAQ
Amotech Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 19:03 UTC, shares in BioSmart Co are trading at KR₩5,340. This share price information is delayed by 15 minutes.
Shares in BioSmart Co last closed at KR₩5,340 and the price had moved by +51.78% over the past 365 days. In terms of relative price strength the BioSmart Co share price has outperformed the FTSE Developed Asia Pacific Index by +52.83% over the past year.
There is no consensus recommendation for this security.
BioSmart Co does not currently pay a dividend.
BioSmart Co does not currently pay a dividend.
BioSmart Co does not currently pay a dividend.
To buy shares in BioSmart Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩5,340, shares in BioSmart Co had a market capitalisation of KR₩110bn.
Here are the trading details for BioSmart Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 038460
Based on an overall assessment of its quality, value and momentum BioSmart Co is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioSmart Co. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +42.09%.
As of the last closing price of KR₩5,340, shares in BioSmart Co were trading +54.71% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The BioSmart Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩5,340.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
BioSmart Co's management team is headed by:
- Hye Rin Park - CHM
- Ho Gwon Yoon - CPR
- Gyeong Taek Han - CPR
- Jong Yil Yim - MDR
- Bong Tae Jang - OTH
- Seong Wuk Jang - OTH
- Tae Gi Yoon - OTH
- Jin Hun Jung - DRC
- Yin Geun Hwang - NID
- Chang Hwan Lee - NID